ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 196 filers reported holding ANIKA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 15.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $366,000 | -7.8% | 16,397 | +67.9% | 0.00% | -40.0% |
| Q2 2019 | $397,000 | -30.0% | 9,768 | -47.9% | 0.01% | -37.5% |
| Q1 2019 | $567,000 | +23.5% | 18,748 | +55.7% | 0.01% | +14.3% |
| Q4 2013 | $459,000 | +45.3% | 12,040 | -9.1% | 0.01% | +40.0% |
| Q3 2013 | $316,000 | +45.6% | 13,240 | +3.9% | 0.01% | +25.0% |
| Q2 2013 | $217,000 | – | 12,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |